Spots Global Cancer Trial Database for contrast agent
Every month we try and update this database with for contrast agent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer | NCT04751747 | Locally Advance... Metastatic Lung... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... Unresectable Lu... | Computed Tomogr... Contrast Agent | 18 Years - | Rutgers, The State University of New Jersey | |
| Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma | NCT03104569 | Cholangitis | Injection of 37... | 18 Years - 90 Years | Hepatopancreatobiliary Surgery Institute of Gansu Province | |
| Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer | NCT03176979 | Breast Carcinom... | Contrast Agent Digital Tomosyn... Dual-Energy Con... | 18 Years - | University of Southern California | |
| MRI in Staging Ovarian Cancer Using MRI Contrast Agent | NCT00463996 | Ovarian Cancer | - | University of Aarhus | ||
| Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy | NCT01894607 | Kidney Cancer | Contrast Enhanc... DEFINITY Phone Call | 18 Years - | M.D. Anderson Cancer Center | |
| Hepatic Xenetix-CT Perfusion | NCT01639703 | Hepatocellular ... | Xenetix-CT perf... | 18 Years - | Guerbet | |
| Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI | NCT01895829 | Head and Neck C... | Magnetic Resona... Ferumoxytol | 18 Years - | M.D. Anderson Cancer Center | |
| Gadopiclenol in Contrast Enhanced MRI of the Prostate | NCT06226129 | Prostate Cancer | Gadopiclenol | 18 Years - | University of Massachusetts, Worcester | |
| BR55 in Prostate Cancer: an Exploratory Clinical Trial | NCT01253213 | Prostate Cancer | BR55 | 40 Years - | Bracco Diagnostics, Inc | |
| Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer | NCT06330805 | Prostate Adenoc... Stage IIB Prost... Stage IIC Prost... | Biospecimen Col... Contrast Agent Leuprolide Magnetic Resona... Physical Perfor... Relugolix | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI | NCT01895829 | Head and Neck C... | Magnetic Resona... Ferumoxytol | 18 Years - | M.D. Anderson Cancer Center | |
| BR55 in Prostate Cancer: an Exploratory Clinical Trial | NCT01253213 | Prostate Cancer | BR55 | 40 Years - | Bracco Diagnostics, Inc | |
| Gadopiclenol in Contrast Enhanced MRI of the Prostate | NCT06226129 | Prostate Cancer | Gadopiclenol | 18 Years - | University of Massachusetts, Worcester | |
| Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications | NCT05046301 | Breast Carcinom... | Biospecimen Col... Contrast Agent Contrast-Enhanc... Questionnaire A... | 25 Years - 85 Years | M.D. Anderson Cancer Center | |
| Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications | NCT05046301 | Breast Carcinom... | Biospecimen Col... Contrast Agent Contrast-Enhanc... Questionnaire A... | 25 Years - 85 Years | M.D. Anderson Cancer Center | |
| Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI | NCT01895829 | Head and Neck C... | Magnetic Resona... Ferumoxytol | 18 Years - | M.D. Anderson Cancer Center | |
| Hepatic Xenetix-CT Perfusion | NCT01639703 | Hepatocellular ... | Xenetix-CT perf... | 18 Years - | Guerbet | |
| Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications | NCT05046301 | Breast Carcinom... | Biospecimen Col... Contrast Agent Contrast-Enhanc... Questionnaire A... | 25 Years - 85 Years | M.D. Anderson Cancer Center | |
| Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors | NCT04265430 | Malignant Oral ... Malignant Skull... Osteoradionecro... | Contrast Agent Magnetic Resona... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| MRI in Staging Ovarian Cancer Using MRI Contrast Agent | NCT00463996 | Ovarian Cancer | - | University of Aarhus | ||
| Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer | NCT06330805 | Prostate Adenoc... Stage IIB Prost... Stage IIC Prost... | Biospecimen Col... Contrast Agent Leuprolide Magnetic Resona... Physical Perfor... Relugolix | 18 Years - | Ohio State University Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
